drying under high vacuum at room temperature for 24 h prior
to use. Amber liquid (71%); 1H NMR (500 MHz, DMSO-d6) d
ppm 7.69 (s, 1H), 7.23 (t, 1H), 6.92 (t, 1H), 4.26 (t, 2H), 3.04
(t, 2H); 13C NMR (125 MHz, DMSO-d6) d ppm 137.3, 128.7,
119.2, 118.5, 41.6, 19.5; FT-IR (nmax in cmÀ1): 3551 (m), 3473
(m), 3413 (w), 3240 (m), 3078 (w), 2966 (w), 2252 (w), 1616 (s),
1538 (m), 1410 (m), 1374 (m), 1376 (m), 1275 (m), 1231 (m),
1181 (m), 1116 (w), 1034 (w), 907 (m), 758 (m), 705 (m).
(nmax in cmÀ1): 3381 (b), 3141 (w), 3060 (m), 2936 (m), 2864
(w), 2242 (w), 1571 (s), 1459 (m), 1426 (m), 1362 (w), 1336 (w),
1167 (s), 1094 (w), 1029 (w), 835 (w), 755 (m), 697 (w).
1-(6-Cyanohexyl)-3-methylimidazolium bromide (9[Br]). Com-
pound 9[Br] was prepared from 1 (1.483 g, 18 mmol). Amber
1
liquid (92%); H NMR (500 MHz, DMSO-d6) d ppm = 9.23
(s, 1H), 7.82 (s, 1H), 7.74 (s, 1H), 4.18 (t, 2H), 3.87 (s, 3H), 2.50
(t, 2H), 1.80 (pent, 2H), 1.55 (pent, 2H), 1.37 (pent, 2H), 1.27
(pent, 2H); 13C NMR (125 MHz, DMSO-d6) d ppm = 137.0,
124.1, 122.7, 121.1, 49.1, 36.2, 29.5, 27.8, 25.1, 24.9, 16.5; FT-IR
(nmax in cmÀ1): 3417 (b), 3141 (w), 3059 (m), 2934 (m), 2861 (w),
2242 (w), 1731 (w), 1570 (s), 1459 (m), 1426 (m), 1365 (w), 1337
(w), 1297 (w), 1246 (w), 1164 (s), 1088 (w), 1046 (w), 1020 (w),
829 (m), 756 (m), 697 (w).
Caution. Acrylonitrile is a very hazardous irritant and
permeator for skin and eyes, and requires protective clothing
and a properly ventilated workspace. Prolonged exposure
should be avoided, as there may be carcinogenic/teratogenic/
mutagenic effects, as well as toxicity related to target organs
including blood, liver, central nervous system, and kidneys.
Additionally, explosive mixtures can be formed when vapors
are allowed to mix with air, and accumulation of evaporated
material is to be avoided. Please refer to Material Safety Data
Sheet (MSDS) for further precautionary details (CAS #107-13-1).
1-(1-Cyanoethyl)-3-methylimidazolium bromide (10[Br]). Com-
pound 10[Br] was prepared from 1 (0.615 g, 7.4 mmol). Yellow
powder (85%); 1H NMR (500 MHz, DMSO-d6) d ppm 9.53
(s, 1H), 8.12 (s, 1H), 7.79 (s, 1H), 6.17 (q, 1H), 3.90 (s, 3H), 1.90
(d, 3H); 13C NMR (125 MHz, DMSO-d6) d ppm 137.5, 125.1,
121.4, 117.5, 45.7, 36.7, 19.5; FT-IR (nmax in cmÀ1): 3172 (w),
3150 (w), 3170 (w), 3043 (s), 3012 (s), 2882 (m), 2847 (w), 2618
(w), 2556 (w), 2249 (w), 1776 (w), 1735 (w), 1654 (w), 1580 (m),
1552 (s), 1448 (m), 1419 (m), 1381 (w), 1324 (w), 1302 (m), 1260
(w), 1182 (s), 1168 (s), 1100 (s), 1020 (m), 989 (w), 892 (w), 863
(s), 843 (m), 768 (s), 717 (m), 674 (w).
1-(2-Cyanoethyl)-3-methylimidazolium bromide (5[Br]). Com-
pound 5[Br] was prepared from 1 (4.621 g, 38 mmol). Yellow
solid (86%); 1H NMR (500 MHz, DMSO-d6) d ppm 9.31 (s, 1H),
7.88 (s, 1H), 7.80 (s, 1H), 4.53 (t, 2H), 3.90 (s, 3H), 3.25 (t, 2H);
13C NMR (125 MHz, DMSO-d6) d ppm 137.5, 124.4, 122.8,
118.2, 44.9, 36.5, 19.2; FT-IR (nmax in cmÀ1): 3139 (w), 3082 (s),
3042 (s), 2958 (w), 2845 (w), 2250 (w), 1780 (w), 1761 (w), 1727
(w), 1676 (w), 1575 (m), 1559 (w), 1448 (w), 1426 (w), 1401 (w),
1359 (w), 1341 (w), 1280 (w), 1199 (w), 1160 (s), 1092 (w), 1022
(w), 892 (w), 864 (s), 789 (s), 741 (s), 652 (m).
1-Butyl-3-(2-cyanoethyl)imidazolium bromide (12[Br]). Com-
pound 12[Br] was prepared by alkylation of 3 (1.521 g, 12 mmol)
with 1-bromobutane (2.125 g, 15 mmol). Yellow solid (86%);
1H NMR (500 MHz, DMSO-d6) d ppm 9.43 (s, 1H), 7.92 (d,
1H), 7.91 (d, 1H), 4.53 (t, 2H), 4.23 (t, 2H), 3.28 (t, 2H), 1.78
(pent, 2H), 1.24 (hex, 2H), 0.89 (t, 3H); 13C NMR (125 MHz,
DMSO-d6) d ppm 136.4, 122.6, 122.3, 117.5, 48.6, 44.3, 31.1,
18.5, 18.5, 13.1; FT-IR (nmax in cmÀ1): 3378 (b), 3134 (w), 3055
(m), 2960 (m), 2935 (m), 2875 (w), 1707 (m), 1640 (w), 1557 (s),
1463 (w), 1421 (w), 1362 (m), 1223 (w), 1160 (s), 1115 (w), 1020
(w), 925 (w), 871 (w), 754 (s), 708 (w).
1-(3-Cyanopropyl)-3-methylimidazolium chloride (6[Cl]). Com-
pound 6[Cl] was prepared from 1 (3.610 g, 44 mmol). Yellow
solid (92%); 1H NMR (500 MHz, DMSO-d6) d ppm 9.42 (s, 1H),
7.87 (t, 1H), 7.78 (t, 1H), 4.28 (t, 2H), 3.86 (s, 3H), 2.61 (t, 2H),
2.14 (pent, 2H); 13C NMR (125 MHz, DMSO-d6) d ppm 136.9,
123.5, 122.2, 119.5, 47.4, 35.6, 25.2, 13.4; FT-IR (nmax in cmÀ1):
3435 (s), 3371 (s), 3244 (w), 3126 (w), 3109 (w), 3063 (m), 2971
(w), 2938 (w), 2915 (w), 2839 (w), 2244 (m), 2186 (w), 2111 (w),
1731 (w), 1655 (w), 1619 (m), 1574 (s), 1562 (s), 1453 (m), 1425
(m), 1391 (w), 1344 (w), 1334 (w), 1325 (w), 1266 (w), 1160 (s),
1092 (s), 1017 (m), 867 (s), 850 (w), 774 (s), 723 (w), 665 (m).
1-(3-Cyanopropyl)-3-butylimidazolium chloride (13[Cl]). Com-
pound 13[Cl] was prepared from 2 (4.969 g, 40 mmol). Amber
liquid (45%); 1H NMR (500 MHz, DMSO-d6) d ppm 9.44
(s, 1H), 7.87 (s, 1H), 7.85 (s, 1H), 4.28 (t, 2H), 4.17 (t, 2H),
2.61 (t, 2H), 2.15 (pent, 2H), 1.78 (pent, 2H), 1.28 (sext, 2H), 0.90
(t, 3H); 13C NMR (125 MHz, DMSO-d6) d ppm 136.3, 122.4,
122.3, 119.5, 48.5, 47.6, 31.1, 25.0, 18.7, 13.4, 13.2;
FT-IR (nmax in cmÀ1): 3372 (b), 3134 (w), 3049 (m), 2959 (m),
2935 (m), 2873 (w), 2245 (s), 1639 (w), 1561 (s), 1370 (w), 1335
(w), 1163 (s), 1115 (w), 1054 (w), 1021 (w), 949 (w), 852 (m),
753 (m).
1-(4-Cyanobutyl)-3-methylimidazolium chloride (7[Cl]). Com-
pound 7[Cl] was prepared from 1 (1.232 g, 15 mmol). Amber
1
liquid (95%); H NMR (500 MHz, DMSO-d6) d ppm = 9.24
(s, 1H), 7.82 (t, 1H), 7.75 (t, 1H), 4.24 (t, 2H), 3.86 (s, 3H), 2.57
(t, 2H), 1.87 (pent, 2H), 1.53 (pent, 2H); 13C NMR (125 MHz,
DMSO-d6) d ppm = 137.1, 124.1, 122.7, 120.9, 48.3, 36.3, 29.0,
22.0, 16.2; FT-IR (nmax in cmÀ1): 3372 (b), 3143 (w), 3058 (m),
2952 (w), 2869 (w), 2242 (w), 1637 (w), 1571 (s), 1458 (m), 1427
(w), 1385 (w), 1335 (w), 1293 (w), 1161 (s), 1091 (w), 1020 (w),
843 (w), 760 (m), 697 (w).
1-(4-Cyanobutyl)-3-butylimidazolium chloride (14[Cl]). Com-
pound 14[Cl] was prepared from 2 (1.870 g, 15 mmol). Amber
liquid (97%); 1H NMR (500 MHz, DMSO-d6) d ppm 9.62
(s, 1H), 7.91 (d, 1H), 7.90 (d, 1H), 4.27 (t, 2H), 4.20 (t, 2H),
2.59 (t, 2H), 1.89 (pent, 2H), 1.78 (pent, 2H), 1.53 (pent, 2H),
1.24 (sext, 2H), 0.89 (t, 3H); 13C NMR (125 MHz, DMSO-d6)
d ppm 136.2, 122.4, 122.3, 120.2, 48.7, 31.1, 28.3, 21.4, 18.6, 15.5,
13.1; FT-IR (nmax in cmÀ1): 3372 (b), 3131 (w), 3046 (m), 2957
(s), 2934 (s), 2872 (m), 2242 (w), 1638 (w), 1561 (s), 1458 (s), 1370
1-(5-Cyanopentyl)-3-methylimidazolium bromide (8[Br]). Com-
pound 8[Br] was prepared from 1 (1.724 g, 21 mmol). Amber
1
liquid (94%); H NMR (500 MHz, DMSO-d6) d ppm = 9.31
(s, 1H), 7.85 (s, 1H), 7.77 (s, 1H), 4.21 (t, 2H), 3.87
(s, 3H), 2.52 (t, 2H), 1.83 (pent, 2H), 1.59 (pent, 2H), 1.33 (pent,
2H); 13C NMR (125 MHz, DMSO-d6) d ppm = 136.8,
123.8, 122.5, 120.8, 48.6, 36.0, 28.8, 24.7, 24.3, 16.3; FT-IR
c
1712 New J. Chem., 2011, 35, 1701–1717
This journal is The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2011